Motus GI cites 38 percent to 96 percent gains: what it means for Motus GI stock
Published on 10/02/2026 at 03:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSMotus GI Holdings, Inc. (ISIN US62014P5044) highlights visualization improvement from 38 percent to 96 percent following use of its Pure-Vu system, according to the company's Motus GI website. The figure gives the small medical-device developer a concrete operating measure as Motus GI stock remains quoted on OTC Markets.
What 38 percent to 96 percent means
The Pure-Vu system is designed to improve visualization during colonoscopy and upper gastrointestinal endoscopy. Motus GI describes the technology as a way to help clinicians address a poorly prepared gastrointestinal tract and proceed with a high-quality procedure the first time.
The range from 38 percent to 96 percent is a company-presented visualization result, not a revenue or earnings measure. Its importance lies in the clinical use case: better visibility can support diagnosis and treatment when blood, clots, debris or inadequate preparation obstruct the procedure.
Historical financial scale
Historical filings show revenue of USD 64,000 in the first quarter of fiscal 2024 and a net loss of USD 2.113 million in the same period. Those figures are historical rather than a current earnings update, but they show the gap between the product opportunity and the company scale recorded in that reporting period, as documented by Canli Capital.
Motus GI's business profile centers on the Pure-Vu system rather than a diversified device portfolio. The company's website also describes the system as relevant to inpatient colonoscopy, clinical evidence and upper gastrointestinal procedures, keeping the investment case closely tied to adoption and clinical utility.
Market value remains limited
As of October 2, 2026, the quote record lists Motus GI at a market capitalization of USD 1,278. A Yahoo Finance market page identifies MOTS as an OTC Markets security and lists Motus GI Holdings, Inc. as the issuer, reinforcing the distinction between this company and similarly named Motus Holdings businesses.
The combination of a 38 percent to 96 percent visualization result and a USD 1,278 market capitalization creates a highly concentrated profile. Product adoption, regulatory progress and new financial reporting would materially shape how the market evaluates Pure-Vu's commercial reach.
Motus GI stock facts
- Company: Motus GI Holdings, Inc.
- ISIN: US62014P5044
- Ticker: MOTS
- Primary exchange: OTC Markets
- Market capitalization: USD 1,278 (as of October 2, 2026)
- Sector / Industry: Healthcare / Medical Devices
